Mineralys Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Mineralys Therapeutics's balance sheet done over the years? Its assets were worth $251,636,000 last year, which is more than in the previous period. 4% of Mineralys Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $10,482,000, which means an decrease by -94% compared compared to last year.
Debt to Assets
| 2020 | 1486000 | 5.08M | 342.06% |
|---|---|---|---|
| 2021 | 11125000 | 34.05M | 306.07% |
| 2022 | 114442000 | 166.71M | 145.67% |
| 2023 | 251636000 | 10.48M | 4.17% |
MLYS Balance Sheet (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 49.30M | 87.70M | 10.61M | 1.40M |
Short term investments | 187.26M | 22.40M | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 12.53M | 2.70M | 510K | 57K |
Total current assets | 249.10M | 110.11M | 11.12M | 1.46M |
Non-current assets: | ||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 2.48M | 0 | 0 | 0 |
Other non-current assets | 51K | 4.33M | 3K | 20K |
Total non-current assets | 2.53M | 4.33M | 3K | 20K |
Total assets | 251.63M | 114.44M | 11.12M | 1.48M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 4.5M |
Total current liabilities | 10.48M | 8.06M | 5.05M | 5.08M |
| Non-current liabilities: | ||||
Long term debt | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 |
Total non-current liabilities | 0 | 158.64M | 28.99M | 0 |
Total liabilities | 10.48M | 166.71M | 34.05M | 5.08M |
| Data source | Data source |